JAGUAR GENE THERAPY
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
JAGUAR GENE THERAPY
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.jaguargenetherapy.com
Total Employee:
11+
Status:
Active
Total Funding:
139 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Content Delivery Network Euro Organization Schema JsDelivr Cloudflare JS
Similar Organizations
Acumen Pharmaceuticals
Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.
Bild
Build hardware faster. better. together.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Joseph McIntosh Chief Medical Officer @ Jaguar Gene Therapy
Chief Medical Officer
Joseph Nolan President and Chief Executive Officer @ Jaguar Gene Therapy
President and Chief Executive Officer
2020-03-01
Phillip Donenberg Chief Financial Officer @ Jaguar Gene Therapy
Chief Financial Officer
Michael B. Johannesen Chief Legal Officer @ Jaguar Gene Therapy
Chief Legal Officer
Sukumar Nagendran President of R&D @ Jaguar Gene Therapy
President of R&D
Andrew Knudten Chief Operating Officer @ Jaguar Gene Therapy
Chief Operating Officer
Investors List
JDRF T1D Fund
JDRF T1D Fund investment in Venture Round - Jaguar Gene Therapy
Samsung Ventures
Samsung Ventures investment in Venture Round - Jaguar Gene Therapy
Deerfield
Deerfield investment in Series B - Jaguar Gene Therapy
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Jaguar Gene Therapy
Sean P. Nolan
Sean P. Nolan investment in Series B - Jaguar Gene Therapy
Nolan Capital
Nolan Capital investment in Series B - Jaguar Gene Therapy
Goldman Sachs
Goldman Sachs investment in Series B - Jaguar Gene Therapy
Eli Lilly
Eli Lilly investment in Series B - Jaguar Gene Therapy
Deerfield
Deerfield investment in Series A - Jaguar Gene Therapy
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-04 | Jaguar snags a CMO after banking $139M to propel its preclinical gene therapies |
Official Site Inspections
http://www.jaguargenetherapy.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.08 K
Unable to get host informations!!!
More informations about "Jaguar Gene Therapy"
About Us - Jaguar Gene Therapy
Jul 11, 2024 We leverage the unparalleled expertise and best-in-class manufacturing process of Advanced Medicine Partners, a wholly owned subsidiary of Jaguar, to harness the proven and …See details»
People - Jaguar Gene Therapy
Across all aspects of our organization, we’ve brought together the experts necessary to build the best gene therapy company. Get to know some of our Jaguars. “At Jaguar, we recognize the urgent need for treatments for the …See details»
Jaguar Gene Therapy - Crunchbase Company Profile & Funding
Jaguar Gene Therapy may be growing as evidenced by several strategic business moves. The company has spun off its manufacturing unit into a separate entity, Advanced Medicine …See details»
Jaguar Gene Therapy - LinkedIn
Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations.See details»
Jaguar Gene Therapy Announces FDA Clearance of IND to Study …
Jan 31, 2024 “As an organization dedicated to expediting life-changing therapies for Phelan-McDermid syndrome, we are thrilled for JAG201 to be cleared for clinical trials,” said Geraldine …See details»
Jaguar Gene Therapy Launches with Mission to …
Feb 25, 2021 Media Julie Normart media@jaguargenetherapy.com 559.974.3245 Release Summary Jaguar Gene Therapy launched today after being in stealth mode for the past year and is uniquely positioned to ...See details»
Jaguar Gene Therapy Announces State-of-the-Art Gene Therapy …
Oct 26, 2021 Company Contact Kate Neer kneer@jaguargenetherapy.com 815.978.3891 Release Summary Jaguar Gene Therapy announces plans for a commercial manufacturing …See details»
Patients & Caregivers - Jaguar Gene Therapy
Type 1 galactosemia is a rare genetic disease that can be life-threatening for newborns and cause severe lifelong complications starting as early as the first year of life. 1,2,3 Galactosemia affects the body’s ability to make the enzyme …See details»
Jaguar Gene Therapy Announces FDA Clearance of IND to Study …
LAKE FOREST, Ill., January 31, 2024--Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic …See details»
Trial Cleared to Start Dosing Pediatric Patients With Autism Due to ...
Jul 16, 2024 Jaguar Gene Therapy has been cleared by the FDA to evaluate its JAG201 gene therapy in pediatric patients with autism spectrum disorder (ASD) due to SHANK3 …See details»
Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led …
Apr 13, 2021 Media Julie Normart media@jaguargenetherapy.com 559.974.3245 Release Summary Jaguar Gene Therapy today announced it has closed a $139 million Series B …See details»
Pipeline - Jaguar Gene Therapy
Jaguar is advancing JAG201, an investigational gene therapy currently in preclinical development that is intended to deliver appropriate SHANK3 genetic function via the AAV9 vector to treat …See details»
Deerfield unveils Jaguar Gene Therapy with 4 preclinical programs …
Feb 25, 2021 Deerfield Management is revealing its latest gene therapy play in a pair of companies working on treatments for rare diseases and the not so rare. | Jaguar Gene …See details»
Jaguar Gene Therapy Announces FDA Clearance of IND to Study
Jan 31, 2024 LAKE FOREST, Ill.--(BUSINESS WIRE)-- Jaguar Gene Therapy a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe …See details»
About Type 1 Galactosemia - jaguargenetherapy.com
May 16, 2022 Company Contact. Kate Neer kneer@jaguargenetherapy.com 815.978.3891. References. 1 Galactosemia. National Organization for Rare Disorders (NORD) Rare Disease …See details»
Jaguar Gene Therapy Announces Target Genes for Initial Pipeline ...
Dec 14, 2021 The company will leverage its internal CMC expertise, its process sciences lab in Cary, North Carolina, and, once fully converted, its recently announced state-of-the-art gene …See details»
Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial ...
LAKE FOREST, Ill., July 09, 2024--Jaguar Gene Therapy, a clinical-stage biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases ...See details»
Jaguar Gene Therapy Announces Preclinical Data Presentations at ...
May 2, 2022 National Organization for Rare Disorders (NORD) Rare Disease Database. 2019. Accessed October 27, 2021. ... Company Kate Neer kneer@jaguargenetherapy.com …See details»
News - Jaguar Gene Therapy
Jan 31, 2024 kneer@jaguargenetherapy.com (815) 978-3891 “Jaguar is uniquely positioned to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases.” …See details»